Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Voriconazole therapeutic drug monitoring.

Literature DB >> 16569888

Voriconazole therapeutic drug monitoring.

J Smith¹, N Safdar, V Knasinski, W Simmons, S M Bhavnani, P G Ambrose, D Andes.

Abstract

We report on 28 patients who underwent voriconazole monitoring because of disease progression or toxicity. A relationship (P<0.025) between disease progression and drug concentration was detected. Favorable responses were observed in 10/10 patients with concentrations above 2.05 microg/ml, while disease progressed in 44% (n=18) of patients with concentrations below 2.05 microg/ml.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2006 PMID： 16569888 PMCID： PMC1426935 DOI： 10.1128/AAC.50.4.1570-1572.2006

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

28 in total

1. Safety of voriconazole and dose individualization.

Authors: Irja Lutsar; Mike R Hodges; Konrad Tomaszewski; Peter F Troke; Nolan D Wood
Journal: Clin Infect Dis Date: 2003-04-15 Impact factor: 9.079

2. The safety of voriconazole.

Authors: Brian A Potoski; Jack Brown
Journal: Clin Infect Dis Date: 2002-11-15 Impact factor: 9.079

3. Pharmacokinetics of voriconazole and cytochrome P450 2C19 genetic status.

Authors: Yasuhiko Ikeda; Kazuo Umemura; Kazunao Kondo; Kaneo Sekiguchi; So Miyoshi; Mitsuyoshi Nakashima
Journal: Clin Pharmacol Ther Date: 2004-06 Impact factor: 6.875

4. Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole.

Authors: Alexander Imhof; S Arunmozhi Balajee; David N Fredricks; Janet A Englund; Kieren A Marr
Journal: Clin Infect Dis Date: 2004-08-13 Impact factor: 9.079

5. Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants.

Authors: Francisco M Marty; Lisa A Cosimi; Lindsey R Baden
Journal: N Engl J Med Date: 2004-02-26 Impact factor: 91.245

6. Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis.

Authors: Greg T Siwek; Kirsty J Dodgson; Margarida de Magalhaes-Silverman; Luther A Bartelt; Sara B Kilborn; Peter L Hoth; Daniel J Diekema; Michael A Pfaller
Journal: Clin Infect Dis Date: 2004-07-30 Impact factor: 9.079

7. Identification of the cytochrome P450 enzymes involved in the N-oxidation of voriconazole.

Authors: R Hyland; B C Jones; D A Smith
Journal: Drug Metab Dispos Date: 2003-05 Impact factor: 3.922

Review 8. Evolving role of flucytosine in immunocompromised patients: new insights into safety, pharmacokinetics, and antifungal therapy.

Authors: P Francis; T J Walsh
Journal: Clin Infect Dis Date: 1992-12 Impact factor: 9.079

9. Voriconazole, a novel wide-spectrum triazole: oral pharmacokinetics and safety.

Authors: Lynn Purkins; Nolan Wood; Katie Greenhalgh; Michael J Allen; Stuart D Oliver
Journal: Br J Clin Pharmacol Date: 2003-12 Impact factor: 4.335

10. Polymorphisms and the pocketbook: the cost-effectiveness of cytochrome P450 2C19 genotyping in the eradication of Helicobacter pylori infection associated with duodenal ulcer.

Authors: David F Lehmann; Joseph J Medicis; Patricia D Franklin
Journal: J Clin Pharmacol Date: 2003-12 Impact factor: 3.126

96 in total

Review 1. Triazole antifungal agents in invasive fungal infections: a comparative review.

Authors: Cornelia Lass-Flörl
Journal: Drugs Date: 2011-12-24 Impact factor: 9.546

2. Concentration of antifungal agents within host cell membranes: a new paradigm governing the efficacy of prophylaxis.

Authors: P Campoli; Q Al Abdallah; R Robitaille; N V Solis; J A Fielhaber; A S Kristof; M Laverdiere; S G Filler; D C Sheppard
Journal: Antimicrob Agents Chemother Date: 2011-09-19 Impact factor: 5.191

Review 3. Pharmacokinetics of antifungal agents in children.

Authors: Kevin Watt; Daniel K Benjamin; Michael Cohen-Wolkowiez
Journal: Early Hum Dev Date: 2011-02-01 Impact factor: 2.079

4. Drug interaction between voriconazole and tacrolimus and its association with the bioavailability of oral voriconazole in recipients of allogeneic hematopoietic stem cell transplantation.

Authors: Takehiko Mori; Jun Kato; Akiko Yamane; Masatoshi Sakurai; Sumiko Kohashi; Taku Kikuchi; Yukako Ono; Shinichiro Okamoto
Journal: Int J Hematol Date: 2012-03-30 Impact factor: 2.490

5. Long-term voriconazole and skin cancer: is there cause for concern?

Authors: Cornelius J Clancy; M Hong Nguyen
Journal: Curr Infect Dis Rep Date: 2011-12 Impact factor: 3.725

6. Multiplex ultra-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification in human plasma of fluconazole, itraconazole, hydroxyitraconazole, posaconazole, voriconazole, voriconazole-N-oxide, anidulafungin, and caspofungin.

Authors: Laurent Arthur Decosterd; Bertrand Rochat; Benoît Pesse; Thomas Mercier; Frédéric Tissot; Nicolas Widmer; Jacques Bille; Thierry Calandra; Boris Zanolari; Oscar Marchetti
Journal: Antimicrob Agents Chemother Date: 2010-09-20 Impact factor: 5.191

Review 7. Pulmonary aspergillosis: clinical presentation, diagnostic tests, management and complications.

Authors: Rami Sherif; Brahm H Segal
Journal: Curr Opin Pulm Med Date: 2010-05 Impact factor: 3.155

8. Human tissue distribution of voriconazole.

Authors: Stefan Weiler; David Fiegl; Róisín MacFarland; Eva Stienecke; Rosa Bellmann-Weiler; Stefan Dunzendorfer; Michael Joannidis; Romuald Bellmann
Journal: Antimicrob Agents Chemother Date: 2010-11-15 Impact factor: 5.191

9. Randomised Comparison of Safety Profile and Short Term Response of Itraconazole, Voriconazole and Amphotericin B in the Management of Chronic Invasive Fungal Rhinosinusitis.

Authors: Santosh Debbarma; Rijuneeta Gupta; Sourabha K Patro; Ashok K Gupta; Promila Pandhi; Nusrat Shafiq
Journal: Indian J Otolaryngol Head Neck Surg Date: 2019-01-24

10. Locally extensive angio-invasive Scedosporium prolificans infection following resection for squamous cell lung carcinoma.

Authors: Natasha E Holmes; Janine M Trevillyan; Sarah E Kidd; Trishe Y-M Leong
Journal: Med Mycol Case Rep Date: 2013-04-19